Lobbying

Dentsply Sirona XRAY's latest lobbying report covers Q4 2025, at $70K. The four quarters Q4 2025–Q3 2026 total $70K. Its first report covers Q1 2025; the issues it reports most are Health Issues and Trade (Domestic & Foreign).

Dentsply SironaXRAY

Dentsply Sirona stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$70K
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2025
The first quarter a report named it

Lobbying by quarter

Dentsply Sirona lobbying by quarter
Dentsply Sirona lobbying by quarter
QuarterAmountReports
Q1 2025$30K2
Q2 2025$130K2
Q3 2025$70K2
Q4 2025$70K2
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$160K · 6 reports
  • Trade$80K · 6 reports
  • Medicare and Medicaid$60K · 4 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES8 reports
  • SENATE8 reports

Firms it paid

Firm
Forbes-Tate$180K4 quarters
In-houseDentsply Sirona$120K4 quarters

Former officials lobbying for it

Former position
MICHAEL ALEXANDER WILLIAMSLegislative Director, Rep. Lucy McBath (2021-2022); Legislative Assistant, Rep. Lucy McBath (2019-2020); Legislative Aide, Sen. Doug Jones (2019); Legislative Correspondent, Sen. Doug Jones (2018-2019).Q2 2025
TORI SMITHPolicy Advisor, Sen. Marsha Blackburn (2023-2025).Q2 2025

Lobbying reports

Filed by
01/22for Q4 2025In-house$20K
01/20for Q4 2025In-houseUnder $5,000
25/12/19for Q4 2025Forbes-Tate$50K
25/10/18for Q3 2025Forbes-Tate$50K
25/10/15for Q3 2025In-house$20K
25/07/18for Q2 2025In-house$80K
25/07/16for Q2 2025Forbes-Tate$50K
25/04/18for Q1 2025Forbes-Tate$30K
25/04/17for Q1 2025In-houseUnder $5,000
25/03/18for Q1 2025In-houseUnder $5,000
25/03/11for Q1 2025Forbes-TateUnder $5,000